AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $958,000 | +101.7% | 27,804 | -2.2% | 0.01% | +150.0% |
| Q2 2020 | $475,000 | +23.7% | 28,437 | +6.7% | 0.00% | 0.0% |
| Q1 2020 | $384,000 | -59.3% | 26,641 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $943,000 | +60.6% | 28,179 | +0.4% | 0.00% | +100.0% |
| Q3 2019 | $587,000 | -0.2% | 28,055 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $588,000 | -5.8% | 28,249 | +1.2% | 0.00% | 0.0% |
| Q1 2019 | $624,000 | -9.4% | 27,915 | -3.1% | 0.00% | -33.3% |
| Q4 2018 | $689,000 | -12.1% | 28,820 | +0.3% | 0.00% | 0.0% |
| Q3 2018 | $784,000 | +3.3% | 28,728 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $759,000 | +5.0% | 28,211 | +24.1% | 0.00% | 0.0% |
| Q1 2018 | $723,000 | -19.3% | 22,726 | -4.1% | 0.00% | 0.0% |
| Q4 2017 | $896,000 | +53.2% | 23,704 | +0.5% | 0.00% | +50.0% |
| Q3 2017 | $585,000 | +30.3% | 23,591 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $449,000 | +27.6% | 21,827 | +34.9% | 0.00% | +100.0% |
| Q1 2017 | $352,000 | +13.9% | 16,184 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $309,000 | -99.9% | 15,114 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $227,310,000 | +38.8% | 15,154 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $163,717,000 | +88.2% | 15,131 | +135.7% | 0.00% | – |
| Q1 2016 | $87,000,000 | – | 6,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |